Tsingyuan Ventures – Tsingyuan Ventures is a technology-focused venture fund investing in seed to A-round startups in the United States. It is a successor fund to the TEEC Angel Fund. We have deep ties to the extensive Tsinghua University network in both the US and China. We have used this network and our technical expertise to source and evaluate some of the best early stage deals in the past six years.

OUR MISSION
Tsingyuan Ventures is a technology-focused venture fund based in Los Altos, California. We invest in seed to A-round startups in the United States. It is a successor fund to the TEEC Angel Fund.

WHO WE ARE

We are a team of seasoned executives and entrepreneurs. We are highly technical, with 7 PhDs and over 150 patents filed among our investment team.

WHAT WE DO

We invest in early stage technology companies and help them grow.

WHERE WE EXCEL

We are deeply technical, and skilled at evaluating emerging technologies. We leverage our experience and connections to help our portfolio companies in funding, market development, and exit opportunities.

MEET OUR TEAM >

WeRide

The first company to launch commercial

service for autonomous taxis in China.

Tsingyuan portfolio company.

Stimwave

Stimwave obtained FDA clearance for its tiny,

MRI-safe neurostimulation device for the treatment

of chronic peripheral nerve pain. Stimwave makes

the leading neurostimulation technology for

management of chronic pain without the use of opioids.

Tsingyuan portfolio company.

Zoom

Zoom Video Communications was named

by top industry analyst, Frost and Sullivan,

their 2019 Company of the Year for the

Global Video Conferencing Industry.

Tsingyuan portfolio company.

Subtle Medical

Subtle Medical received FDA 510(k) clearance for

enhancing PET scan images using their AI

technology. Next up: MRI enhancements.

Tsingyuan portfolio company.

Ginkgo Bioworks

Ginkgo Bioworks is beginning to create animal cells.

(opening markets for immunotherapies, anti-bodies, etc)

(Oct 24, 2018) TEEC Angel Fund (Tsingyuan Ventures’

previous fund) portfolio company.

WHO WE ARE

WHAT WE DO

WHERE WE EXCEL

WeRide

The first company to launch commercial service for autonomous taxis in China. Tsingyuan portfolio company.

Stimwave

Stimwave obtained FDA clearance for its tiny, MRI-safe neurostimulation device for the treatment of chronic peripheral nerve pain. Stimwave makes the leading neurostimulation technology for management of chronic pain without the use of opioids. Tsingyuan portfolio company.

Zoom

Zoom Video Communications was named by top industry analyst, Frost and Sullivan, their 2019 Company of the Year for the Global Video Conferencing Industry. Tsingyuan portfolio company.

Subtle Medical

Subtle Medical received FDA 510(k) clearance for enhancing PET scan images using their AI technology. Next up: MRI enhancements. Tsingyuan portfolio company.

Ginkgo Bioworks

Ginkgo Bioworks is beginning to create animal cells. (opening markets for immunotherapies, anti-bodies, etc) (Oct 24, 2018) TEEC Angel Fund (Tsingyuan Ventures’ previous fund) portfolio company.

WHO WE ARE

WHAT WE DO

WHERE WE EXCEL

The first company to launch commercial

service for autonomous taxis in China.

Tsingyuan portfolio company.

Stimwave obtained FDA clearance for its tiny,

MRI-safe neurostimulation device for the treatment

of chronic peripheral nerve pain. Stimwave makes

the leading neurostimulation technology for

management of chronic pain without the use of opioids.

Tsingyuan portfolio company.

Zoom Video Communications was named

by top industry analyst, Frost and Sullivan,

their 2019 Company of the Year for the

Global Video Conferencing Industry.

Tsingyuan portfolio company.

Subtle Medical received FDA 510(k) clearance for

enhancing PET scan images using their AI

technology. Next up: MRI enhancements.

Tsingyuan portfolio company.

Ginkgo Bioworks is beginning to create animal cells.

(opening markets for immunotherapies, anti-bodies, etc)

(Oct 24, 2018) TEEC Angel Fund (Tsingyuan Ventures’

previous fund) portfolio company.